TRANSCRANIAL BONE MARROW INJECTION
Clinical trials for TRANSCRANIAL BONE MARROW INJECTION explained in plain language.
Never miss a new study
Get alerted when new TRANSCRANIAL BONE MARROW INJECTION trials appear
Sign up with your email to follow new studies for TRANSCRANIAL BONE MARROW INJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Bone marrow injection shows promise for severe stroke
Disease control Not yet recruitingThis early-phase study tests a new drug called RK-4 for people with a severe type of stroke (large hemispheric infarction) who cannot have standard clot-removal treatment. The drug is injected directly into the skull bone marrow once daily for three days. The main goals are to ch…
Matched conditions: TRANSCRANIAL BONE MARROW INJECTION
Phase: PHASE1, PHASE2 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Bone marrow injection into skull shows promise for severe stroke recovery
Disease control Not yet recruitingThis study tests a new drug called RK-4, injected directly into the skull bone marrow, for people with a severe type of stroke (large hemispheric infarction) who cannot have standard blood vessel treatments. About 194 participants will either get the RK-4 injection daily for 3 da…
Matched conditions: TRANSCRANIAL BONE MARROW INJECTION
Phase: PHASE2 • Sponsor: Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC